234 related articles for article (PubMed ID: 33841413)
21. Sterile inflammation induces vasculopathy and chronic lung injury in murine sickle cell disease.
Rarick KR; Li K; Teng RJ; Jing X; Martin DP; Xu H; Jones DW; Hogg N; Hillery CA; Garcia G; Day BW; Naylor S; Pritchard KA
Free Radic Biol Med; 2024 Mar; 215():112-126. PubMed ID: 38336101
[TBL] [Abstract][Full Text] [Related]
22. Erythrocyte and plasma oxidative stress appears to be compensated in patients with sickle cell disease during a period of relative health, despite the presence of known oxidative agents.
Detterich JA; Liu H; Suriany S; Kato RM; Chalacheva P; Tedla B; Shah PM; Khoo MC; Wood JC; Coates TD; Milne GL; Oh JY; Patel RP; Forman HJ
Free Radic Biol Med; 2019 Sep; 141():408-415. PubMed ID: 31279092
[TBL] [Abstract][Full Text] [Related]
23. Heme-mediated cell activation: the inflammatory puzzle of sickle cell anemia.
Guarda CCD; Santiago RP; Fiuza LM; Aleluia MM; Ferreira JRD; Figueiredo CVB; Yahouedehou SCMA; Oliveira RM; Lyra IM; Gonçalves MS
Expert Rev Hematol; 2017 Jun; 10(6):533-541. PubMed ID: 28482712
[TBL] [Abstract][Full Text] [Related]
24. Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.
Camus SM; De Moraes JA; Bonnin P; Abbyad P; Le Jeune S; Lionnet F; Loufrani L; Grimaud L; Lambry JC; Charue D; Kiger L; Renard JM; Larroque C; Le Clésiau H; Tedgui A; Bruneval P; Barja-Fidalgo C; Alexandrou A; Tharaux PL; Boulanger CM; Blanc-Brude OP
Blood; 2015 Jun; 125(24):3805-14. PubMed ID: 25827830
[TBL] [Abstract][Full Text] [Related]
25. S100A8 acts as an autocrine priming signal for heme-induced human Mϕ pro-inflammatory responses in hemolytic inflammation.
Silveira AAA; Mahon OR; Cunningham CC; Corr EM; Mendonça R; Saad STO; Costa FF; Dunne A; Conran N
J Leukoc Biol; 2019 Jul; 106(1):35-43. PubMed ID: 31091351
[TBL] [Abstract][Full Text] [Related]
26. Toll-like receptor 4 region Glu24-Lys47 is a site for MD-2 binding: importance of CYS29 and CYS40.
Nishitani C; Mitsuzawa H; Sano H; Shimizu T; Matsushima N; Kuroki Y
J Biol Chem; 2006 Dec; 281(50):38322-9. PubMed ID: 17056597
[TBL] [Abstract][Full Text] [Related]
27. Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence.
Gentinetta T; Belcher JD; Brügger-Verdon V; Adam J; Ruthsatz T; Bain J; Schu D; Ventrici L; Edler M; Lioe H; Patel K; Chen C; Nguyen J; Abdulla F; Zhang P; Wassmer A; Jain M; Mischnik M; Pelzing M; Martin K; Davis R; Didichenko S; Schaub A; Brinkman N; Herzog E; Zürcher A; Vercellotti GM; Kato GJ; Höbarth G
J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160081
[TBL] [Abstract][Full Text] [Related]
28. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM
Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345
[TBL] [Abstract][Full Text] [Related]
29. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
Nader E; Romana M; Connes P
Front Immunol; 2020; 11():454. PubMed ID: 32231672
[TBL] [Abstract][Full Text] [Related]
30. Endothelial activation by platelets from sickle cell anemia patients.
Proença-Ferreira R; Brugnerotto AF; Garrido VT; Dominical VM; Vital DM; Ribeiro Mde F; dos Santos ME; Traina F; Olalla-Saad ST; Costa FF; Conran N
PLoS One; 2014; 9(2):e89012. PubMed ID: 24551209
[TBL] [Abstract][Full Text] [Related]
31. Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.
Vinchi F; Costa da Silva M; Ingoglia G; Petrillo S; Brinkman N; Zuercher A; Cerwenka A; Tolosano E; Muckenthaler MU
Blood; 2016 Jan; 127(4):473-86. PubMed ID: 26675351
[TBL] [Abstract][Full Text] [Related]
32. The inflammatory profiles of pulmonary alveolar macrophages and alveolar type 2 cells in SCD.
Gbotosho OT; Li W; Joiner CH; Brown LAS; Hyacinth HI
Exp Biol Med (Maywood); 2023 Jun; 248(12):1013-1023. PubMed ID: 37012678
[TBL] [Abstract][Full Text] [Related]
33. Differences in heme and hemopexin content in lipoproteins from patients with sickle cell disease.
Vendrame F; Olops L; Saad STO; Costa FF; Fertrin KY
J Clin Lipidol; 2018; 12(6):1532-1538. PubMed ID: 30219641
[TBL] [Abstract][Full Text] [Related]
34. Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease.
Yalamanoglu A; Deuel JW; Hunt RC; Baek JH; Hassell K; Redinius K; Irwin DC; Schaer DJ; Buehler PW
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L765-L774. PubMed ID: 30047285
[TBL] [Abstract][Full Text] [Related]
35. Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.
Vercellotti GM; Zhang P; Nguyen J; Abdulla F; Chen C; Nguyen P; Nowotny C; Steer CJ; Smith A; Belcher JD
Mol Med; 2016 Sep; 22():437-451. PubMed ID: 27451971
[TBL] [Abstract][Full Text] [Related]
36. Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components.
Talreja J; Kabir MH; B Filla M; Stechschulte DJ; Dileepan KN
Immunology; 2004 Oct; 113(2):224-33. PubMed ID: 15379983
[TBL] [Abstract][Full Text] [Related]
37. Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia.
Belcher JD; Gomperts E; Nguyen J; Chen C; Abdulla F; Kiser ZM; Gallo D; Levy H; Otterbein LE; Vercellotti GM
PLoS One; 2018; 13(10):e0205194. PubMed ID: 30308028
[TBL] [Abstract][Full Text] [Related]
38. Characterization of monoclonal antibodies to human soluble MD-2 protein.
Viriyakosol S; McCray PB; Ashbaugh ME; Chu J; Jia HP; Weiss J; Kirkland TN
Hybridoma (Larchmt); 2006 Dec; 25(6):349-57. PubMed ID: 17203997
[TBL] [Abstract][Full Text] [Related]
39. Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation.
Zhang Y; Chen H; Zhang W; Cai Y; Shan P; Wu D; Zhang B; Liu H; Khan ZA; Liang G
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165683. PubMed ID: 31953218
[TBL] [Abstract][Full Text] [Related]
40. Sickle red blood cell-derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factor.
An R; Man Y; Cheng K; Zhang T; Chen C; Wang F; Abdulla F; Kucukal E; Wulftange WJ; Goreke U; Bode A; Nayak LV; Vercellotti GM; Belcher JD; Little JA; Gurkan UA
Br J Haematol; 2023 May; 201(3):552-563. PubMed ID: 36604837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
